AP
HPTX

AlpInvest Partners’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

AlpInvest Partners’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7,920
Closed -$207K – 32
2014
Q2 		$207K Buy
+7,920
New +$204K 0.74% 17

Other funds holding HPTX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AlpInvest Partners's HPTX Position: Q3 2014 in Review

AlpInvest Partners sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q3 2014, closing a stake of 7,920 shares — an estimated $207K sold.

AlpInvest Partners first reported a position in HPTX in Q2 2014 and held it in 1 quarter. The position peaked at $207K in Q2 2014. 97 funds tracked by Wall St. Rank hold HPTX as of Q3 2014.

  • AlpInvest Partners reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • AlpInvest Partners sold 7,920 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $207K.
  • AlpInvest Partners first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • AlpInvest Partners's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $207K in Q2 2014.
  • 97 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on AlpInvest Partners's 13F filing for Q3 2014, filed 14 Nov 2014.